EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project

Not Applicable

Terminated

Conditions: HIV

Interventions: Behavioral: Reducing Risk Behavior
Behavioral: Support and Guidance

First Posted Date: 2015-09-29

Last Posted Date: 2021-01-22

Lead Sponsor: Emory University

Target Recruit Count: 2

Registration Number: NCT02562092

Locations: 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Ponce De Leon Center, Atlanta, Georgia, United States

Bela 8 Week Dosing

Phase 4

Completed

Conditions: Kidney Transplantation

Interventions: Drug: Belatacept

First Posted Date: 2015-09-25

Last Posted Date: 2020-09-18

Lead Sponsor: Emory University

Target Recruit Count: 166

Registration Number: NCT02560558

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Clinic, Atlanta, Georgia, United States

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

Phase 2

Suspended

Conditions: Stress Disorders, Post-Traumatic

Interventions: Procedure: Microneurography
Behavioral: Combat virtual reality video clip
Procedure: Handgrip Exercise
Procedure: Cold Pressor Test (CPT)
Drug: Sodium Nitroprusside (SNP)
Drug: Phenylephrine
Drug: Losartan
Drug: Atenolol

First Posted Date: 2015-09-25

Last Posted Date: 2024-02-14

Lead Sponsor: Emory University

Target Recruit Count: 134

Registration Number: NCT02560805

Locations: 🇺🇸
Atlanta VA Medical Center, Decatur, Georgia, United States

Technology-based Eye Care Services (TECS) Compare

Not Applicable

Completed

Conditions: Cataract
Glaucoma
Macular Degeneration

Interventions: Other: Technology-based Eye Care Services (TECS) Protocol

First Posted Date: 2015-09-24

Last Posted Date: 2018-04-13

Lead Sponsor: Emory University

Target Recruit Count: 256

Registration Number: NCT02558712

Locations: 🇺🇸
Atlanta VA Medical Center, Decatur, Georgia, United States

Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery

Phase 4

Completed

Conditions: Hyperglycemia

Interventions: Drug: Placebo
Drug: Sitagliptin
Drug: Regular Human Insulin
Drug: Insulin glargine
Drug: Supplemental insulin (Insulin lispro)
Drug: Supplemental insulin (Insulin aspart)

First Posted Date: 2015-09-22

Last Posted Date: 2019-12-23

Lead Sponsor: Emory University

Target Recruit Count: 202

Registration Number: NCT02556918

Locations: 🇺🇸
Emory Univeristy Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Emergence of Generative Language

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Mand Training
Behavioral: Matrix
Behavioral: Stimulus Equivalence Training

First Posted Date: 2015-09-21

Last Posted Date: 2016-12-05

Lead Sponsor: Emory University

Target Recruit Count: 9

Registration Number: NCT02555241

Customized Cortical Stimulation Therapy in the Rehabilitation of Stroke Patients

Not Applicable

Terminated

Conditions: Stroke

Interventions: Device: Single-pulse Transcranial Magnetic Stimulation (TMS)
Device: Paired-pulse Transcranial Magnetic Stimulation (ppTMS)
Device: Low-frequency Repetitive Transcranial Magnetic Stimulation (rTMS)
Device: Sham Motor Cortex Stimulation

First Posted Date: 2015-09-09

Last Posted Date: 2023-08-31

Lead Sponsor: Emory University

Target Recruit Count: 100

Registration Number: NCT02544503

Locations: 🇺🇸
Center for Rehabilitation Medicine, Atlanta, Georgia, United States
🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Computer-Based Intervention in HIV-Positive Young Adults

Not Applicable

Withdrawn

Conditions: Depression
HIV

Interventions: Behavioral: Screen-based health education
Device: Electronic Self-Management Resource Training for Mental Health

First Posted Date: 2015-09-09

Last Posted Date: 2017-01-24

Lead Sponsor: Emory University

Registration Number: NCT02544126

Arginine Therapy for Sickle Cell Disease Pain

Phase 2

Completed

Conditions: Sickle Cell Disease
Vaso-occlusive Pain Episode

Interventions: Other: Placebo
Drug: L-arginine
Drug: L-arginine Loading Dose

First Posted Date: 2015-08-31

Last Posted Date: 2023-09-06

Lead Sponsor: Emory University

Target Recruit Count: 108

Registration Number: NCT02536170

Locations: 🇺🇸
Children's Healthcare of Atlanta at Hugh Spalding, Atlanta, Georgia, United States
🇺🇸
Children's Healthcare of Atlanta at Scottish Rite, Atlanta, Georgia, United States
🇺🇸
Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States

Field Implementation of iDETECT

Completed

Conditions: Brain Trauma
Concussion

Interventions: Device: integrated Display Enhanced Testing for Cognitive Impairment and mild traumatic brain injury (iDETECT)
Device: Riddell High Impact Technology (HIT) System
Device: i1 Biometrics Vector Mouth Guard

First Posted Date: 2015-08-20

Last Posted Date: 2016-03-04

Lead Sponsor: Emory University

Target Recruit Count: 124

Registration Number: NCT02529618

Locations: 🇺🇸
Marietta High School, Marietta, Georgia, United States
🇺🇸
Blessed Trinity Catholic High School, Roswell, Georgia, United States
🇺🇸
Westminster High School, Atlanta, Georgia, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy